Opioid Use in Pelvic Fractures: The Impact of Opioid Prescribing Laws in Pennsylvania.
Document Type
Article
Publication Date
3-22-2024
Abstract
Pennsylvania's Prescription Drug Monitoring Program (PDMP) was established in 2016, but its impact on opioid use for pelvic fractures is understudied. We compared opioid use in 277 pelvic fracture cases between two periods: 2015-2017 (T1) and 2018-2020 (T2). Outcomes included daily inpatient morphine milligram equivalents (MME), long-term opioid use (LOU) 60-90 days post-discharge, and intermediate-term opioid use (IOU) 30-60 days post-discharge. T1 and T2 had comparable baseline characteristics. T2 was associated with a decrease in average daily inpatient MME (58.6 vs 78.5,
Publication Title
The American surgeon
First Page
31348241241644
Last Page
31348241241644
Recommended Citation
Villa, N., Shum, K., Atkinson, A., Ong, A., Muller, A., & Espiridion, E. (2024). Opioid Use in Pelvic Fractures: The Impact of Opioid Prescribing Laws in Pennsylvania.. The American surgeon, 31348241241644-31348241241644. https://doi.org/https://doi.org/10.1177/00031348241241644
Comments
Online ahead of print